Impact of Reimbursement Cuts on the Sustainability and Accessibility of Dopamine Transporter Imaging

Reimbursement levels, payor mix, scanner location, and radiopharmaceutical costs are all critical, variable factors for modeling the financial viability of I-123 ioflupane imaging and, by extrapolation, future radiopharmaceuticals.